![Sample our Bioscience journals, sign in here to start your access, Latest two full volumes FREE to you for 14 days]({"type":"image" , "src" : "/sda/5925/TOC-Subject-Sample-2021-Bioscience.jpg"})
Abstract
Efavirenz is dosed once daily, and is generally administered in the evening owing to its central nervous system side-effects. This study assessed the tolerability of switching to morning dosing of efavirenz. Of the 49 patients included, 24 chose to continue morning dosing. Morning dosing of efavirenz may result in fewer side-effects and improved adherence for some patients.